LCRF Minority Career Development Award (CDA) in Lung Cancer

The objective of this award is to increase the number of highly skilled and trained researchers from groups that are historically underrepresented in academia, medicine, and leadership in lung cancer research.

Focus Areas

• They encourage applications on a wide variety of topics including but not limited to the following:
  • Lung cancer biology
  • Risk reduction and screening for early detection
  • Identification of new biomarkers
  • Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
  • Genetic and gene-environment interactions
  • Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
  • Mechanisms of sensitivity and resistance to lung cancer therapies
  • Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene-therapy)
  • Supportive measures for people with lung cancer and their families
  • Identification of metabolic vulnerabilities in lung cancer
  • Real world data to discover where and why disparities exist, to fill gaps for new drugs’ approval, or to create eligibility criteria that reflect patient community that will use the drugs
  • Access to reliable and affordable biomarker testing, quality care, appropriate treatment options.

Funding Information

• The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).

Eligibility Criteria

• Investigators must be from racial or ethnic groups that are underrepresented in health-related sciences and biomedical research. This includes Blacks or African Americans, Hispanics or Latinos, American Indians or Alaskan Natives, Native Hawaiians and other Pacific Islanders.
• Individuals from racial or ethnic groups that can demonstrate convincingly that they are underrepresented by the host institution will also be eligible.
• Investigators will need to fill out demographic information and provide a short statement from their Institution indicating their eligibility. Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators within 10 years of receiving their MD and/or Ph.D. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics. Exceptions may also be made for those who did training outside the US.
• Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status. Applicants may only apply for one LCRF grant per grant cycle.
• Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years.
• Applicants are prohibited from applying in more than one of LCRF’s funding tracks in the same cycle.
• Ineligible applications and new requests under special circumstances will not be considered after submission deadline.

For more information, visit LCRF.